KESORAMIND SHARE PRICE PREDICTION
Recommendation → Expensive Rocket
- Week
- Month
- 3 Month
- Year
Open |
215.13
|
High |
215.13
|
Low |
212.18
|
52-Wk High |
229.66
|
52-Wk Low |
93.95
|
Interpretation of Candlestick Chart
Hanging Man Considering these factors, the current market outlook for KESORAMIND suggests a challenging environment for buyers, with the potential for further downside movement in the short term.
KESORAMIND Share price Prediction:-
Period | Target 1 | Target 2 |
---|---|---|
2024 | 94.89 | 229.68 |
2025 | 96.5 | 231.29 |
2026 | 98.11 | 232.9 |
2027 | 99.72 | 234.51 |
2028 | 101.33 | 236.12 |
2029 | 102.94 | 237.73 |
2030 | 104.55 | 239.34 |
2031 | 106.16 | 240.95 |
2032 | 107.77 | 242.56 |
2033 | 109.38 | 244.17 |
2034 | 110.99 | 245.78 |
KESORAMIND share price target 2024 to 2034 :-
KESORAMIND’s share price target is the estimated value of the stock at a given point in time. It is based on our research, history, fundamentals, market trends and other factors.
2024
The minimum share price target for KESORAMIND shares is Rs 94.89 and the maximum
target
price is Rs 229.68 by 2024
- Target1 : 94.89
- Target 2 : 229.68
2025
The minimum share price target for KESORAMIND shares is Rs 96.5 and the
maximum target price is Rs 231.29 by
2025
- Target1 : 96.5
- Target 2 : 231.29
2026
The minimum share price target for KESORAMIND shares is Rs 98.11 and the
maximum target price is Rs 232.9 by
2026
- Target1 : 98.11
- Target 2 : 232.9
2027
The minimum share price target for KESORAMIND shares is Rs 99.72 and the
maximum target price is Rs 234.51 by
2027
- Target1 : 99.72
- Target 2 : 234.51
2028
The minimum share price target for KESORAMIND shares is Rs 101.33 and the
maximum target price is Rs 236.12 by
2028
- Target1 : 101.33
- Target 2 : 236.12
2029
The minimum share price target for KESORAMIND shares is Rs 102.94 and the
maximum target price is Rs 237.73 by
2029
- Target1 : 102.94
- Target 2 : 237.73
2030
The minimum share price target for KESORAMIND shares is Rs 104.55 and the
maximum target price is Rs 239.34 by
2030
- Target1 : 104.55
- Target 2 : 239.34
2031
The minimum share price target for KESORAMIND shares is Rs 106.16 and the
maximum target price is Rs 240.95 by
2031
- Target1 : 106.16
- Target 2 : 240.95
2032
The minimum share price target for KESORAMIND shares is Rs 107.77 and the
maximum target price is Rs 242.56 by
2032
- Target1 : 107.77
- Target 2 : 242.56
2033
The minimum share price target for KESORAMIND shares is Rs 109.38 and the
maximum target price is Rs 244.17 by
2033
- Target1 : 109.38
- Target 2 : 244.17
2034
The minimum share price target for KESORAMIND shares is Rs 110.99 and the
maximum target price is Rs 245.78 by
2034
- Target1 : 110.99
- Target 2 : 245.78
**KESORAMIND share price target prediction for 2024, 2025, and 2026 through 2034 is based on growth assumptions, future forecasts, and the existing state of the market. It is subject to change dependent on market sentiment.
KESORAMIND Past Performance:-
1 Day →
1 Week →
1 Month →
3 Month →
1 Year →
Simple Moving Average (SMA) of KESORAMIND :-
SMA 5 → 209.92
SMA 34 → 216.34
SMA 20 → 212.39
SMA 13 → 209.93
SMA 89 → 214.63
SMA 200 → 191.74
Exponential Moving Average (EMA) of KESORAMIND :-
EMA 5 → 210.19
EMA 34 → 213.09
EMA 20 → 211.98
EMA 13 → 210.75
EMA 89 → 212.73
EMA 200 → 188.12
Bollinger Band KESORAMIND :-
BBand Upper → 221.94
BBand Lower → 202.83
BBand Mid → 212.39
Moving Average Convergence KESORAMIND :-
MACD →
MACD Signal →
MACD Hist →
Past Performance
KESORAMIND Change in 1 day
-1.61%
Change in 1 day
KESORAMIND Change in 1 Week
4.30%
Change in 1 Week
KESORAMIND Change in 1 Month
-5.11%
Change in 1 Month
KESORAMIND Change in 3 Month
-1.96%
Change in 3 Month
KESORAMIND Change in 1 Year
177.48%
Change in 1 Year
What is the current share price of KESORAMIND ?
What is the target of KESORAMIND tomorrow?
What is the full form of KESORAMIND ?
Can I invest in KESORAMIND share?
Is KESORAMIND a buy hold or sell?
Durability : 0.46
Valuation : 0
Momentum : 86.58
Therefore, as per risk appetite of the investor whether to buy hold or sell the KESORAMIND at current level.